[{"AccountsPayableCurrent_0_Q2_USD":4243000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":209000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":0.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":200000000.0,"ProceedsFromContributedCapital_2_Q2_USD":129000.0,"PrepaidExpenseCurrent_0_Q2_USD":4840000.0,"PreferredStockValueOutstanding_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":62000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":0.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-711000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-84000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-740000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":740000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":169000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":169000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":740000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":169000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":727000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":551000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2731000.0,"RelatedPartyTransactionAmountsOfTransaction_1_Q2_USD":800000.0,"RelatedPartyTransactionAmountsOfTransaction_2_Q2_USD":900000.0,"RepaymentsOfNotesPayable_2_Q2_USD":0.0,"ResearchAndDevelopmentExpense_1_Q2_USD":21361000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":103558036.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":109078427.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":200000000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":0.0,"StockholdersEquity_0_Q2_USD":536397000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":10.05,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":23.68,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":19.26,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":8.96,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":6156944.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":2316000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1082000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":7.21,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":2471739.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":40626.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":9.06,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2372363.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":1318000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":4963197.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"ShareBasedCompensation_2_Q2_USD":12222000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-266831000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":40066000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":680310.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":109078427.0,"OperatingLeaseExpense_2_Q2_USD":600000.0,"OperatingExpenses_2_Q2_USD":67535000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-67434000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-37534000.0,"CommonStockValue_0_Q2_USD":12000.0,"CommonStockSharesOutstanding_0_Q2_shares":114998871.0,"CommonStockSharesIssued_0_Q2_shares":114998871.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"CommonStockNoParValue_0_Q2_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":14524238.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":158806000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":558952000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":558952000.0,"AssetsCurrent_0_Q2_USD":563792000.0,"Assets_0_Q2_USD":566732000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":9561041.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":11489000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":7669000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":7669000.0,"AdditionalPaidInCapital_0_Q2_USD":802774000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":442000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":761000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":23058000.0,"AccruedBonusesCurrent_0_Q2_USD":1792000.0,"ConvertiblePreferredStockSharesReservedForFutureIssuance_0_Q2_shares":10000.0,"Depreciation_2_Q2_USD":54000.0,"EarningsPerShareBasic_1_Q2_USD":-0.35,"EarningsPerShareBasic_2_Q2_USD":-0.66,"OperatingExpenses_1_Q2_USD":37650000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"NetIncomeLoss_2_Q2_USD":-68174000.0,"NetIncomeLoss_1_Q2_USD":-37703000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-41261000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-62000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":200129000.0,"LiabilitiesCurrent_0_Q2_USD":28383000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":566732000.0,"Liabilities_0_Q2_USD":30335000.0,"OperatingLeaseExpense_1_Q2_USD":300000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-4021000.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":1810000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-72000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-31000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-68246000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-37734000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":27469000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":16289000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.0011,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.0008,"EarningsPerShareDiluted_2_Q2_USD":-0.66,"EarningsPerShareDiluted_1_Q2_USD":-0.35,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":7898000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":103558036.0,"Ticker":"IMVT","CIK":"1764013","name":"IMMUNOVANT, INC.","OfficialName":"Immunovant Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"407422400.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]